Drug intelligence / Profile preview

clofenotane

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Topical, Inhalation
01

Overview

Clofenotane, also known as DDT (dichlorodiphenyltrichloroethane), is a synthetic organochlorine insecticide that was widely used for agricultural and public health purposes, especially in the mid-twentieth century. It is a colorless, crystalline compound with almost no odor or taste. Clofenotane acts primarily as a central nervous system stimulant in insects by interfering with sodium channel function and antagonizing GABA-gated chloride channels, leading to paralysis and death of target pests. First synthesized in 1874, its insecticidal properties were discovered by Paul Hermann Müller in 1939. Clofenotane was extensively used during World War II to control vector-borne diseases such as malaria and typhus but has since been banned or restricted in many countries due to environmental persistence, bioaccumulation, endocrine-disrupting effects, carcinogenic potential, and ecological toxicity. Despite bans for agricultural use in most countries since the 1970s–2000s (including the US ban in 1972), it remains permitted for disease vector control under specific international agreements where alternatives are not available[1][3][4][8].

Brand names
GespanGesarolGeverol
Other names
DDTdichlorodiphenyltrichloroethanechlorophenotane
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)

Beyond the preview

Go deeper on clofenotane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clofenotane.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call